Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies
Articles > Article · 2025
Authors: Nalan Gülşen ÜNAL, HALE AKPINAR, ENGİN ALTINTAŞ, AYKUT FERHAT ÇELİK
LANCET, Journal Indexed in SCI Expanded, International, 2025, vol 405, pp 33-49